← FDA Drug Approvals (Drugs@FDA)

LIKMEZ

NDA · New Drug Application · Sponsor: SAPTALIS PHARMS · Approved 2023-09-22

Drug application

FDA Application #

NDA216755

Application type

New Drug Application

Brand name

LIKMEZ

Generic name

METRONIDAZOLE ORAL

Active ingredients

METRONIDAZOLE

Dosage form

SUSPENSION

Route

ORAL

Marketing status

Prescription

Sponsor

SAPTALIS PHARMS

Manufacturer

Kesin Pharma Corporation

First approval

2023-09-22

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown